CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Minapharm Pharmaceuticals SAE is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Minapharm Pharmaceuticals SAE
El-Bardissi St.
2T Takseem Asmaa Fahmy St.
Phone: +20 224143170p:+20 224143170 CAIRO, Egypt Ticker: MIPHMIPH
Business Summary
Minapharm Pharmaceuticals SAE is an Egypt-based company engaged in the production and distribution of pharmaceutical products. The Company’s production falls into seven lines, namely Gastroenterology, Ophthalmology, Cardiology, Biogenetics, Dermatology, Dermatology, Orthopedic and Miscellaneous products such as betolvex, broncho-vaxom adult, broncho-vaxom infantile, burinex, chlorhexidine tulle, chlorhexidine tulle, ciloprine, daktacort cream, daktarin cream, desatura, dicynone, among others. Minapharm is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Managing Director Wafiq S.Al Bardisi
Non-Executive Vice Chairman of the Board Amro S.Al Shabrawishi
Finance Manager SamehGeorge
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Minapharm Pharmaceuticals
MIPH

General Information
Number of Employees: 838 (As of 12/31/2014)
Outstanding Shares: 12,293,440 (As of 6/30/2024)
Stock Exchange: CAI
Fax Number: +20 224143179


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024